Preoperative Electroencephalography-Based Machine Learning Predicts Cognitive Deterioration After Subthalamic Deep Brain Stimulation

Geraedts VJ, Koch M, Kuiper R, Kefalas M, Bäck THW, van Hilten JJ, Wang H, Middelkoop HAM, van der Gaag NA, Contarino MF, Tannemaat MR.

Mov Disord. 2021 Oct;36(10):2324-2334. doi: 10.1002/mds.28661. Epub 2021 Jun 3.

Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Randomization Approach

Kusters CDJ, Paul KC, Duarte Folle A, Keener AM, Bronstein JM, Bertram L, Hansen J, Horvath S, Sinsheimer JS, Lill CM, Ritz BR.

Mov Disord. 2021 Oct;36(10):2264-2272. doi: 10.1002/mds.28760. Epub 2021 Aug 23.

Zonisamide in Parkinson's disease: a current update

Goel A, Sugumaran R, Narayan SK.

Neurol Sci. 2021 Oct;42(10):4123-4129. doi: 10.1007/s10072-021-05550-2. Epub 2021 Aug 27.

Muscarinic acetylcholine receptor M1 mutations causing neurodevelopmental disorder and epilepsy

Marcé-Grau A, Elorza-Vidal X, Pérez-Rius C, Ruiz-Nel Lo A, Sala-Coromina J, Gabau E, Estévez R, Macaya A.

Hum Mutat. 2021 Oct;42(10):1215-1220. doi: 10.1002/humu.24252. Epub 2021 Jul 10.

Deep brain stimulation in patients on chronic antiplatelet or anticoagulation treatment

Runge J, Cassini Ascencao L, Blahak C, Kinfe TM, Schrader C, Wolf ME, Saryyeva A, Krauss JK.

Acta Neurochir (Wien). 2021 Oct;163(10):2825-2831. doi: 10.1007/s00701-021-04931-y. Epub 2021 Aug 3.

Quantifying Parkinson's disease motor severity under uncertainty using MDS-UPDRS videos

Lu M, Zhao Q, Poston KL, Sullivan EV, Pfefferbaum A, Shahid M, Katz M, Kouhsari LM, Schulman K, Milstein A, Niebles JC, Henderson VW, Fei-Fei L, Pohl KM, Adeli E.

Med Image Anal. 2021 Oct;73:102179. doi: 10.1016/j.media.2021.102179. Epub 2021 Jul 21.

Genetic Stratification of Age-Dependent Parkinson's Disease Risk by Polygenic Hazard Score

Pihlstrøm L, Fan CC, Frei O, Tan M, Karunamuni RA, Blauwendraat C, Bandres-Ciga S, Gan-Or Z, Grosset DG; International Parkinson's Disease Genomics Consortium (IPDGC), Dale AM, Seibert TM, Andreassen

Mov Disord. 2021 Oct 6. doi: 10.1002/mds.28808. Online ahead of print.

Dream Content Predicts Motor and Cognitive Decline in Parkinson's Disease

Otaiku AI.

Mov Disord Clin Pract. 2021 Aug 9;8(7):1041-1051. doi: 10.1002/mdc3.13318. eCollection 2021 Oct.

Hyperkinetic stereotyped movements in a boy with biallelic CNTNAP2 variants

Scala M, Anijs M, Battini R, Madia F, Capra V, Scudieri P, Verrotti A, Zara F, Minetti C, Vernes SC, Striano P.

Ital J Pediatr. 2021 Oct 12;47(1):208. doi: 10.1186/s13052-021-01162-w.

Perception of yips among professional Japanese golfers: perspectives from a network modelled approach

Revankar GS, Kajiyama Y, Gon Y, Ogasawara I, Hattori N, Nakano T, Kawamura S, Ugawa Y, Nakata K, Mochizuki H.

Sci Rep. 2021 Oct 11;11(1):20128. doi: 10.1038/s41598-021-99128-9.

Anesthesia for deep brain stimulation: an update

Dinsmore M, Venkatraghavan L.

Curr Opin Anaesthesiol. 2021 Oct 1;34(5):563-568. doi: 10.1097/ACO.0000000000001038.

DRPLA: An unusual disease or an underestimated cause of ataxia in Brazil?

Pinto WBVR, Salomão RPA, Bergamasco NC, da Cunha Ribas G, da Graça FF, Lopes-Cendes I, Bonadia L, de Souza PVS, Bulle Oliveira AS, Saraiva-Pereira ML, Jardim LB, Tumas V, Junior WM, França MC Jr, Pedr

Parkinsonism Relat Disord. 2021 Oct 11;92:67-71. doi: 10.1016/j.parkreldis.2021.10.004. Online ahead of print.

Parkinsonism in viral, paraneoplastic, and autoimmune diseases

Xing F, Marsili L, Truong DD.

J Neurol Sci. 2021 Oct 1:120014. doi: 10.1016/j.jns.2021.120014. Online ahead of print.

GlcNAc-Asn (GNA) is a biomarker for NGLY1 deficiency

Mueller WF, Zhu L, Tan B, Dwight S, Beahm B, Wilsey M, Wechsler T, Mak J, Cowan T, Pritchett J, Taylor E, Crawford BE.

J Biochem. 2021 Oct 26:mvab111. doi: 10.1093/jb/mvab111. Online ahead of print.

Translational Model of Cortical Premotor-Motor Networks

Kreis SL, Luhmann HJ, Ciolac D, Groppa S, Muthuraman M.

Cereb Cortex. 2021 Oct 23:bhab369. doi: 10.1093/cercor/bhab369. Online ahead of print.